Position in LLY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$13,330,466
+$2,518,570 QoQ
Shares Held
11,114
-5.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#1,101
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Carnegie Investment Counsel holds $159,457,484 across 11 Drug Manufacturers - General names. LLY ranks #4 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
182,419 | $45,903,917 | |
| 2 | AMGN |
Amgen Inc
|
103,528 | $37,489,559 | |
| 3 | JNJ |
Johnson & Johnson
|
132,112 | $33,552,484 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
11,114 | $13,330,466 | |
| 5 | MRK |
Merck & Co., Inc.
|
71,923 | $9,242,105 | |
| 6 | NVO |
Novo Nordisk A S
|
170,256 | $8,162,072 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
35,216 | $4,449,189 | |
| 8 | PFE |
Pfizer Inc
|
129,803 | $3,125,656 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,330,466 | 11,114 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $10,811,896 | 11,755 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $12,401,808 | 11,540 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $9,487,142 | 12,434 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $9,800,251 | 12,572 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $7,746,209 | 9,379 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $6,532,664 | 8,462 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $6,439,011 | 7,268 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $6,167,448 | 6,812 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $5,217,777 | 6,707 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $3,899,734 | 6,690 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $3,585,342 | 6,675 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $3,275,356 | 6,984 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,987,371 | 5,787 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $2,116,018 | 5,784 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $1,803,969 | 5,579 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $2,386,657 | 7,361 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $2,210,776 | 7,720 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $2,239,591 | 8,108 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $1,429,737 | 6,188 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $1,435,877 | 6,256 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $1,121,106 | 6,001 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $927,606 | 5,494 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $812,629 | 5,490 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $902,333 | 5,496 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $867,693 | 6,255 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||